BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24477274)

  • 1. Phosphatidylserine exposure, microparticle formation and mitochondrial depolarisation in Glanzmann thrombasthenia platelets.
    Wang H; Bang KW; Blanchette VS; Nurden AT; Rand ML
    Thromb Haemost; 2014 Jun; 111(6):1184-6. PubMed ID: 24477274
    [No Abstract]   [Full Text] [Related]  

  • 2. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
    Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
    Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.
    Mor-Cohen R; Rosenberg N; Peretz H; Landau M; Coller BS; Awidi A; Seligsohn U
    Thromb Haemost; 2007 Dec; 98(6):1257-65. PubMed ID: 18064323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry.
    Albanyan A; Al-Musa A; AlNounou R; Al Zahrani H; Nasr R; AlJefri A; Saleh M; Malik A; Masmali H; Owaidah T
    Int J Lab Hematol; 2015 Aug; 37(4):503-8. PubMed ID: 25537026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macromolecular architecture of platelet-derived microparticles.
    Tamir A; Sorrentino S; Motahedeh S; Shai E; Dubrovsky A; Dahan I; Eibauer M; Studt JD; Sapra KT; Varon D; Medalia O
    J Struct Biol; 2016 Mar; 193(3):181-187. PubMed ID: 26767592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple, novel and robust test to diagnose type I Glanzmann thrombasthenia.
    Vijapurkar M; Ghosh K; Shetty S; McLane MA; Moura da Silva AM; Butera D
    Haematologica; 2008 May; 93(5):797-8. PubMed ID: 18450741
    [No Abstract]   [Full Text] [Related]  

  • 7. A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.
    Akuta K; Kashiwagi H; Yujiri T; Nishiura N; Morikawa Y; Kato H; Honda S; Kanakura Y; Tomiyama Y
    J Thromb Haemost; 2019 Jan; 17(1):206-219. PubMed ID: 30388316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interesting variations on how a disease is defined: comparisons of von Willebrand disease and Glanzmann thrombasthenia.
    Nurden AT
    J Thromb Haemost; 2007 Mar; 5(3):647-9; author reply 649-51. PubMed ID: 17166245
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural history of platelet antibody formation against αIIbβ3 in a French cohort of Glanzmann thrombasthenia patients.
    Fiore M; Firah N; Pillois X; Nurden P; Heilig R; Nurden AT
    Haemophilia; 2012 May; 18(3):e201-9. PubMed ID: 22250950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
    Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
    Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
    Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia.
    French DL; Seligsohn U
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):607-10. PubMed ID: 10712380
    [No Abstract]   [Full Text] [Related]  

  • 13. Two novel ITGA2B mutations in a Glanzmann thrombasthaenia family associated with different platelet phenotypic expression.
    Daidone V; Bury L; Milan M; Galletta E; Gresele P; Casonato A
    Blood Transfus; 2017 Sep; 15(5):487-488. PubMed ID: 27416581
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations of the platelet proteome in type I Glanzmann thrombasthenia caused by different homozygous delG frameshift mutations in ITGA2B.
    Loroch S; Trabold K; Gambaryan S; Reiß C; Schwierczek K; Fleming I; Sickmann A; Behnisch W; Zieger B; Zahedi RP; Walter U; Jurk K
    Thromb Haemost; 2017 Feb; 117(3):556-569. PubMed ID: 28078347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterisation of enucleated cells apoptosis: human platelets and erythrocytes].
    Mindukshev IV; Rukoiatkina NI; Dobrylko IA; Skverchinskaia EA; Nikitina ER; Krivoshlyk VV; Gambarian SP; Krivchenko AI
    Ross Fiziol Zh Im I M Sechenova; 2013 Jan; 99(1):92-110. PubMed ID: 23659060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glanzmann thrombasthenia-like syndromes associated with Macrothrombocytopenias and mutations in the genes encoding the αIIbβ3 integrin.
    Nurden AT; Pillois X; Fiore M; Heilig R; Nurden P
    Semin Thromb Hemost; 2011 Sep; 37(6):698-706. PubMed ID: 22102273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylserine surface expression and integrin alpha IIb beta 3 activity on thrombin/convulxin stimulated platelets/particles of different sizes.
    Rukoyatkina N; Begonja AJ; Geiger J; Eigenthaler M; Walter U; Gambaryan S
    Br J Haematol; 2009 Feb; 144(4):591-602. PubMed ID: 19036116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets.
    Unsworth AJ; Bye AP; Tannetta DS; Desborough MJR; Kriek N; Sage T; Allan HE; Crescente M; Yaqoob P; Warner TD; Jones CI; Gibbins JM
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1482-1493. PubMed ID: 28619996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A frameshift mutation at Gly975 in the transmembrane domain of GPIIb prevents GPIIb-IIIa expression--analysis of two novel mutations in a kindred with type I glanzmann thrombasthenia.
    Scott JP; Scott JP; Chao YL; Newman PJ; Ward CM
    Thromb Haemost; 1998 Oct; 80(4):546-50. PubMed ID: 9798966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.